
    
      Enrollment breakdown: Entered Study: Phase 1a: 39; Phase 1b: 19; Phase 2a: 33; Total: 91
      Entered Treatment: Phase 1a: 38; Phase 1b: 17; Phase 2a: 26; Total: 81
    
  